TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

InterCure Ltd. (INCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 70 million ILS. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement INCR
Line item Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q1 24 Q2 24 Q3 24 Q1 25 Q2 25 Q3 25 Q1 26 LTM
101 106 106 102 73 63 63 57 65 65 70 70 270
54 80 72 70 55 42 42 56 45 45 70 70 229
46 26 34 33 18 21 21 0.2 20 20 0.2 0.2 41
0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4
14 58 13 12 10 9.5 9.5 18 7.6 7.6 14 14 43
31 27 28 26 57 16 16 39 17 17 17 17 68
16 -1.6 5.9 5.8 -27 5.3 5.3 -39 2.9 2.9 -16 -16 -27
4.4 4.2 5.7 6.1 – 4.5 4.5 4.5 4.0 4.0 5.0 5.0 18
12 -8.7 1.8 0.4 -32 0.7 0.7 -44 -1.1 -1.1 -21 -21 -44
3.6 -14 1.7 -3.3 1.9 0.7 0.7 -8.0 -0.2 -0.2 -3.4 -3.4 -7.3
7.3 5.3 0.2 4.9 -34 0.7 0.7 -35 -0.9 -0.9 -17 -17 -36
19 -6.1 11 9.0 -4.8 7.2 7.2 -47 7.1 7.1 -35 -35 -55

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?